Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment
Main Authors: | Maicol Bissaro, Stefano Moro |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=12;spage=2083;epage=2085;aulast=Bissaro |
Similar Items
-
Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
by: Matthew D. Cykowski, et al.
Published: (2018-04-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
by: Piotr Włodarczyk, et al.
Published: (2022-12-01) -
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
by: Terry R. Suk, et al.
Published: (2020-08-01) -
TDP-43 based biomarker development in amyotrophic lateral sclerosis
by: Feneberg, E
Published: (2019) -
Intracellular Conformation of Amyotrophic Lateral Sclerosis-Causative TDP-43
by: Akira Kitamura, et al.
Published: (2023-03-01)